Abbott Laboratories: A Thorn Amidst the Roses of London’s Investment Spring 🌹

The filing, dated October 14, revealed a holding grown to 940,187 shares-a $125.93 million grove now comprising 2.01% of the fund’s arboreal expanse. This position, though outside their top holdings, stands as a testament to Abbott’s enduring sapling-like promise in the investment soil.







